The European Medicines Agency (EMA) has recommended extending the use of Ofev (nintedanib) to include treating progressive fibrosing interstitial lung diseases (ILDs) in children and adolescents ...

use in children and adolescents with progressive fibrosing interstitial lung diseases (ILDs), after missing an expanded approval in the US earlier this year. The positive opinion could lead to the ...

Ageing naturally weakens the immune system, leaving older adults more susceptible to infections. In older populations, HMPV ...

Ty Hafan's hospice, overlooking the serene view of the sea in Sully in the Vale of Glamorgan, has been providing essential ...

Belimumab is under clinical development by GSK and currently in Phase III for Rheumatoid Arthritis. According to GlobalData, Phase III drugs for Rheumatoid Arthritis have a 63% phase transition ...

Boehringer Ingelheim’s Ofev has become the first med recommended for treating progressive fibrosing interstitial lung disease in children from the age of 6. The condition is rare, affecting less ...

That void hampers an understanding of how disease progresses in children and adolescents and what the outcomes are. Childhood interstitial lung disease encompasses a range of rare respiratory ...

Medically reviewed by Jennifer Steinhoff, MD Radon poisoning occurs when you become exposed to dangerously high levels of ...

EastEnders star Colin Salmon has been married for 35 years and has previously credited his beloved wife as his motivation for ...

Boehringer Ingelheim has won a positive European Medicines Agency (EMA) recommendation for blockbuster Ofev’s (nintedanib) use in children and adolescents with progressive fibrosing interstitial lung ...

Here are the top medical news for the dayInnovative System to Auto-Detect Infectious Disease Variants Could Revolutionize ...

International collaborations, the Children's Interstitial and Diffuse Lung Disease Research Network in the USA and the European Management Platform for Childhood Interstitial Lung Disease (chILD-EU) ...